Neogen Corp. buy melinda
Start price
04.04.17
/
50%
€21.34
Target price
02.06.17
€22.32
Performance (%)
4.72%
End price
02.06.17
€22.35
Summary
This prediction ended on 02.06.17 with a price of €22.35. With a performance of 4.72%, the BUY prediction by melinda for Neogen Corp. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Neogen Corp. | 2.727% | 2.727% | -25.658% | -71.750% |
iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
According to melinda what are the pros and cons of Neogen Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Neogen Corp. diskutieren
Gesundheit | Diagnostic Substances | Vereinigte Staaten
hat $
(Zielkurs erreicht)
Stopped prediction by melinda for Neogen Corp.
Neogen Corp.
Start price
Target price
Perf. (%)
€35.40
14.12.21
14.12.21
€38.00
14.12.22
14.12.22
-59.89%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Neogen Corp.
Start price
Target price
Perf. (%)
€28.63
17.11.18
17.11.18
€30.22
22.01.19
22.01.19
-4.58%
22.01.19
22.01.19
Could be worthwhile Investment >10% per year
Neogen Corp.
Start price
Target price
Perf. (%)
€11.09
28.09.13
28.09.13
€11.75
27.11.13
27.11.13
20.15%
27.11.13
27.11.13
Could be worthwhile Investment >10% per year